Experience the intimate atmosphere of the Kleine Zaal during your conference or meeting. Former boat builders have completely covered the hall with wood, which contributes to its warm appearance. It feels like all 408 seats are front row, as close as you sit to the stage as a visitor.
This hall is particularly beloved by musicians due to its excellent acoustics, which give concerts a unique sound and depth. Speakers also highly appreciate the hall, especially because of the proximity to the audience. This not only enhances interaction and creates an engaged atmosphere but also puts the speaker at ease.
De Kleine Zaal grenst aan de Boven Foyer en wordt meestal gebruikt als plenaire ruimte of als subzaal naast de Grote Zaal. De totale capaciteit bedraagt 408, maar wanneer het balkon (125 zitplaatsen) wordt gesloten, blijft er beneden een capaciteit van 283 over. Door de warme uitstraling is deze zaal ook populair voor video- of tv-opnames.
Every two years, Foundation TWijs organizes a study day for the 31 affiliated primary schools in South Kennemerland. Around 750 teachers, principals, and administrators from this partnership gathered in the PHIL for a plenary information session in the Grote Zaal, followed by inspiring and creative workshops in four smaller rooms. The day was, of course, concluded with a pleasant networking reception.
Our building is regularly used as a filming location for movies, TV shows, or commercials. Recently, recordings were made in our Kleine Zaal for the campaign VGZ helps to innovate healthcare with Eva Eikhout. Just look at our beautiful hall shining in this charming commercial!
For the second time, the PHIL was the venue for the prestigious international ICPR conference (Interdisciplinary Conference on Psychedelic Research). Our client, OPEN Foundation, is a non-profit organization dedicated to promoting knowledge and understanding of psychedelics through research. Not only was the PHIL well-rated, but the city of Haarlem was also so positively reviewed by academics, therapists, scientific researchers, clinical staff, and policymakers in 2022 that it became a reason to return in 2024.
